Investing Profile

Robert Nelsen

VCInvestorAngel

Co-founder and a Managing Director of ARCH Venture Partners

archventure.com/team/robert-t...New York, New York

Your Intro Paths to Robert Nelsen

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Robert Nelsen on

Current Investing Position

ARCH Venture Partners Managing Director

Investment Range

$50K - $150.0M

Sweet Spot

$75.0M

Investments On Record

Current Fund Size

$635.8M

Robert Nelsen is on these Sector & Stage Rankings

BioTech (Seed)BioTech (Series A)Seattle / Portland AI (Seed)AI (Series A)New York City San Francisco Bay Area Midwest Angel, Scout, and Solo-Capitalists Wellness & Fitness (Series A)Wellness & Fitness (Seed)Therapeutics (Series A)Therapeutics (Seed)SaaS (Series A)Digital Health (Series A)Digital Health (Seed)SaaS (Seed)

Robert Nelsen's Investments On Record (52)

Company	StageDateRound Size	Total Raised
Be Biopharma	Series CJan 2025$92M Series UnknownOct 2024$82M Series BApr 2022$130M	$360M
Co-investors: Jason Rhodes (Atlas Venture), Steven Gillis (ARCH Venture Partners), Melissa McCracken (Nextech Invest)
City Therapeutics	Series AOct 2024$140M	$140M
Co-investors: Ari Nowacek (ARCH Venture Partners)
Stability AI	Series UnknownJun 2024$80M	$210M £89M
Co-investors: Gaurav Gupta (Lightspeed Venture Partners), Colin Bryant (New Enterprise Associates (NEA)), Walter Kortschak (Summit Partners), Jim O'Shaughnessy (O'Shaughnessy Ventures), Eric Schmidt (Innovation Endeavors), Dana Settle (Greycroft), Effie Epstein (Sound Ventures), Guy Oseary (Sound Ventures), Ashton Kutcher (Sound Ventures), Chris Denny-Brown (O'Shaughnessy Ventures), Mei Z.
Vilya	Series AJun 2024$21M Series AAug 2022$50M	$71M
Co-investors: Greg Yap (Menlo Ventures), Steven Gillis (ARCH Venture Partners)
Gameto	Series BMay 2024$33M Series AJan 2022$20M	$73M
Co-investors: Dan Rose (Coatue), Dylan Morris (Insight Partners), Steve Jurvetson (Future Ventures), Maryanna Saenko (Future Ventures), Jack Abraham (Atomic), Dusan Perovic (Two Sigma Ventures), Peter Kolchinsky (RA Capital), Laura Stoppel (RA Capital), Anne Wojcicki
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Vikram Bajaj (Foresite Capital)
Seaport Therapeutics	Series AApr 2024$100M	$330M
Co-investors: James Healy (Sofinnova Investments), Brett Zbar (General Atlantic)
Moonwalk Biosciences	Series AJan 2024$57M	$57M